Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Braunau Am Inn – page 6

77 clinical trials in Braunau Am Inn, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Braunau Am Inn at a glance
77
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

77 trials in Braunau Am Inn

Open in trial search
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:GSKVx000000017064
  • Sponsor:GlaxoSmithKline Biologicals

Cardiac failure

Not recruiting

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:Astrazeneca AB

Hypercholesterolaemia

Not recruiting

Study on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Type 2 diabetes mellitus+2

Not recruiting

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Orforglipron hemicalcium
  • Sponsor:Eli Lilly & Co.

Neoplasm malignant

Not recruiting

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut Für Frauengesundheit GmbH

Study of LY3473329 for Adults with High Lipoprotein(a) Levels at Risk for Heart Problems

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Muvalaplin
  • Sponsor:Eli Lilly & Co.

Study on Peppermint Oil and Caraway Oil for Patients with Functional Gastrointestinal Disorders

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Caraway Oil
  • Sponsor:Dr. Willmar Schwabe GmbH & Co. KG

Back pain

Not recruiting

Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aceclofenac
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Braunau Am Inn

What the registry says about research in the country

01 Cardiovascular Disease Prevention

Innovative research focusing on stroke prevention and managing atrial fibrillation, with trials evaluating new anticoagulant therapies and comparing their effectiveness to existing treatments.

  • Stroke Prevention Studies
  • Atherosclerotic Disease Management
  • Blood Clot Prevention

Studies are investigating novel approaches to reduce cardiovascular events in high-risk patients.

02 Heart Failure Research

Comprehensive studies examining treatments for chronic heart failure, particularly in patients with reduced ejection fraction and kidney function impairment.

  • Combination Therapy Evaluation
  • Cardiac Function Improvement
  • Quality of Life Assessment

Research aims to enhance treatment outcomes and reduce hospitalization rates.

03 Cardiomyopathy Studies

Advanced research into both obstructive and non-obstructive hypertrophic cardiomyopathy, evaluating innovative treatments to improve patient symptoms and physical capabilities.

  • Cardiac Structure Analysis
  • Exercise Capacity Improvement
  • Symptom Management

Trials focus on structural heart changes and functional improvements.

04 Metabolic Disease Management

Investigating treatments for patients with type 2 diabetes and obesity, focusing on cardiovascular risk reduction and improved metabolic outcomes.

  • Diabetes Treatment Optimization
  • Weight Management
  • Cardiovascular Risk Reduction

Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.